Dublin, Oct. 09, 2026 (GLOBE NEWSWIRE) -- "Responsive Neurostimulation System (RNS) - Market Insights, Competitive Landscape, and Market Forecast - 2034" has been added to ResearchAndMarkets.com's ...

When you hear the words “brain surgery,” it is absolutely normal to feel terrified. For a person living with epilepsy, the ...

NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its management team will participate in the upcoming ...

In the late 1990s, a young Michael Kahana—then developing computer models of human memory—was invited to Harvard Medical School by a neurosurgeon friend to give grand rounds to the neurosurgery and ...

NeuroPace Inc has introduced the RNS System, a brain-responsive neurostimulation device designed for adults suffering from drug-resistant focal epilepsy. The RNS System continuously monitors brain ...

OpenAI’s first foray into hardware devices is reported to be a mobile smart speaker with integrated AI capabilities that can sync with ChatGPT and provide other home AI services. Bloomberg reported ...

SALT LAKE CITY (ABC4) — Intermountain Health neurologists are celebrating a major surgical milestone: the 100th use of an implantable device that reduces seizure activity in patients with focal ...

The clinical home ecosystem has become the defining phrase of the 2025 to 2026 wellness spending cycle, as buyers stack cold plunges, red light beds and neurotech into serious at-home recovery setups.

This week, Neurovalens‘ Modius Spero became the first neuromodulation device to earn FDA approval to treat PTSD. Veterans, who face disproportionately high PTSD rates, will be the first to gain access ...

Aurenar received FDA Breakthrough Device designation for its V-Link System, a wearable device designed to reduce cerebral vasospasm in adults with aneurysmal subarachnoid hemorrhage. The designation ...